CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, United States
Disclosure information not submitted.
Comparing Safety and Effectiveness of Pfizer BA.4-5 and Sanofi bivalent COVID-19 Vaccines Used in the Spring 2023 Booster Programme in England: a Target Trial Emulation Study Using the OpenSAFELY Platform
Monday, August 26, 20241:30 PM – 1:45 PM CEST
Extending randomized trial estimates to different target populations: An application to a nested trial comparing anticoagulant regimens for percutaneous coronary intervention
Wednesday, August 28, 20242:00 PM – 2:15 PM CEST
